What Is Peptide Therapy? A Straightforward Explanation

Peptides: The Short Version

Your body runs on chemical signals. Hormones tell organs what to do. Neurotransmitters tell nerves when to fire. Growth factors tell cells when to divide. Peptides are another class of these signaling molecules, and your body produces thousands of them.

A peptide is a short chain of amino acids. Shorter than a protein (which can be hundreds or thousands of amino acids long), but built from the same building blocks. Insulin is a peptide. Oxytocin is a peptide. The endorphins your body releases after exercise are peptides.

Peptide therapy takes specific peptides that your body already uses for signaling and delivers them in therapeutic doses. The idea is not to introduce something foreign. It is to amplify a signal your body already recognizes.

BPC-157, for instance, is a fragment of a protein found in human gastric juice. Your stomach already makes it. Therapeutic BPC-157 is a synthetic copy of that same 15-amino-acid sequence, delivered at higher concentrations to promote tissue repair in areas your body might not reach efficiently on its own.

How Peptide Therapy Actually Works

Different peptides do different things. There is no single "peptide effect." But the general mechanism is the same: a peptide binds to a receptor on a cell surface, and that binding triggers a downstream biological response.

Think of it like a key in a lock. The peptide is the key. The receptor is the lock. When the key turns, the cell does something: releases a hormone, starts a repair cascade, modulates an immune response, or changes how it processes energy.

CJC-1295 and Ipamorelin bind to receptors on the pituitary gland that trigger growth hormone release. The pituitary does the work. The peptide just sends the signal. This is fundamentally different from injecting synthetic growth hormone directly, because your pituitary's own feedback mechanisms stay active. When GH levels rise high enough, your body slows production on its own. The guardrails remain in place.

BPC-157 works through a different pathway. It upregulates VEGF (vascular endothelial growth factor), which tells your body to build new blood vessels at an injury site. More blood supply means more oxygen, more nutrients, and faster repair. It also modulates the nitric oxide system and influences multiple growth factor pathways simultaneously, which is why its effects show up across so many tissue types.

MOTS-c activates the AMPK pathway in cells, essentially flipping the same metabolic switch that exercise does. Epitalon activates telomerase in the pineal gland. Thymosin Alpha-1 trains T-cells in the thymus. Each peptide has a specific target and a specific mechanism.

What Peptides Are Not

Peptides get lumped in with steroids, SARMs, and performance-enhancing drugs. The pharmacology is completely different.

Anabolic steroids are synthetic versions of testosterone. They directly flood your body with a hormone, which suppresses your natural production (sometimes permanently). SARMs bind to androgen receptors and mimic testosterone's effects on muscle tissue. Both carry well-documented risks to the liver, cardiovascular system, and endocrine function.

Peptides do not replace your hormones. They do not bind to androgen receptors. They signal your body to do more of what it already does. The distinction matters because it changes the risk profile substantially. When you stop taking a peptide, your body's own production has not been suppressed. There is no "crash" or post-cycle therapy required.

The Major Categories

Therapeutic peptides fall into a handful of categories based on what they target. Here are the main ones, with the most commonly prescribed peptide in each group.

These categories overlap. GHK-Cu is both a longevity peptide and a tissue repair peptide. CJC-1295/Ipamorelin affects sleep quality even though it is classified as a growth hormone peptide. The body does not respect neat categories, and neither do peptides.

The Evidence Question

This is the part most peptide websites skip. The evidence base varies widely across peptides, and being honest about that is important.

Strong evidence (100+ published papers, some human data)

BPC-157 has over 100 published studies spanning 30 years. Most are animal models, but a 2021 clinical study on knee osteoarthritis patients reported that 87.5% experienced significant pain relief lasting 6 to 12 months. A 2025 systematic review of the full literature found consistent healing effects across multiple tissue types. Tesamorelin has full FDA approval for a specific indication (HIV-associated lipodystrophy) and has been through Phase III clinical trials. Thymosin Alpha-1 is approved as a prescription medication in over 35 countries.

Moderate evidence (solid preclinical data, limited human studies)

CJC-1295 and Ipamorelin have well-documented mechanisms and human pharmacokinetic data showing they reliably increase growth hormone levels. Sermorelin was FDA-approved in the 1990s for GH deficiency in children (later discontinued for commercial reasons, not safety). MOTS-c has strong preclinical data from the Lee Lab at USC, including published mouse studies showing metabolic benefits equivalent to regular exercise.

Early evidence (promising mechanism, needs more human data)

Epitalon has compelling telomerase activation data from Vladimir Khavinson's research group in Russia, but lacks Western peer-reviewed clinical trials. GHK-Cu has well-established wound healing and skin regeneration properties, with thousands of studies on the GHK tripeptide, though most are dermatological rather than systemic. Selank and Semax were developed and approved as prescription medications in Russia but have limited English-language clinical trial data.

What Treatment Looks Like

A legitimate peptide therapy protocol follows a straightforward path. You complete a health screening. A licensed provider reviews your medical history and determines whether a specific peptide is appropriate for your situation. If it is, they write a prescription. A 503A compounding pharmacy fills the prescription and ships the peptide directly to you, fully reconstituted and ready to use.

Most peptides are administered by subcutaneous injection, which means a small insulin-type needle injected into the fat layer under the skin, typically in the abdomen or thigh. The needles are 29 to 31 gauge, about the width of a human hair. Most patients report that after the first couple of injections, they barely feel it.

Protocols typically run 8 to 12 weeks. Some peptides are taken daily. Others follow a 5-days-on, 2-days-off schedule. Your provider determines the specific dosing and duration based on your health profile and goals.

A few peptides are available as oral capsules (BPC-157 capsules are the most common). Oral bioavailability is lower than injection, but for gut-specific issues or patients who prefer to avoid needles, oral delivery can still be effective.

How to Tell a Real Provider from a Fake One

This matters more than most people realize. The peptide market has a legitimate side and a gray market, and the gray market is large.

Red flags

No prescription required. Peptides sold as "research chemicals" or "for research purposes only." No medical provider reviews your health history. The website does not list a pharmacy partner. Prices that are dramatically lower than clinical providers (you are probably getting under-dosed or mislabeled product). Lyophilized powder that requires you to reconstitute it yourself with bacteriostatic water.

Green flags

A licensed provider evaluates your health screening before prescribing. Peptides are compounded at an FDA-registered 503A pharmacy. The product ships fully reconstituted and ready to use. Third-party testing for potency, sterility, endotoxin, and pH. Cold-chain shipping (FedEx Overnight or similar) to maintain stability. The provider can answer questions about your protocol and adjust dosing if needed.

What It Costs

Peptide therapy is not covered by insurance in most cases. Monthly costs through a legitimate telehealth provider typically range from $199 to $349 per month depending on the peptide and supply duration. That includes the provider consultation, the prescription, pharmacy compounding, and shipping.

Multi-month supplies usually come with a discount. At PeRx, a single-peptide protocol starts at $199 per month, and combination products (two peptides in one vial) start at $299 per month. Longer commitments reduce the per-month cost.

Gray-market peptides are cheaper, often $30 to $80 per vial. But you are paying less because there is no physician oversight, no pharmacy testing, and no guarantee of what is in the vial. For most patients, the peace of mind that comes with a real prescription and tested product is worth the cost difference.

Who Is This For (and Who Should Wait)

Frequently Asked Questions